bpc-157 fda status 2024 2025 U.S. | FDA is moving at the pace of innovation Is BPC-157 Banned? Oral vs.

The vial contains BPC-157 only

Some practitioners run continuous protocols, but cycling remains the conservative approach until more long-term data exists

In the absence of safety data, most clinicians advise that pregnant or breastfeeding individuals avoid this compounded preparation unless the anticipated benefit clearly outweighs theoretical fetal or neonatal risks

AOD-9604 in obese murine models: the 14-day intraperitoneal data The primary AOD-9604 rodent study used 14 days of intraperitoneal administration at 2 mg/kg per day in obese (ob/ob) mice

Without rehabilitation, peptides alone are unlikely to produce lasting structural improvement